Vaccine Development for Group A Streptococcus Infections and Associated Diseases

By  

Current Drug Targets, Vol. 5, Iss. 1, 2004-01 ,pp. : 57-69

Bentham Science Publishers

Access to resources Recommend Favorite

Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers

By  

Current Pharmaceutical Design, Vol. 18, Iss. 18, 2012-06 ,pp. : 2591-2606

Bentham Science Publishers

Access to resources Recommend Favorite

Vaccine strategies for infectious diseases

By Clerici M.   Piconi S.   Trabattoni D.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 2, 1999-02 ,pp. : 95-106

Informa Healthcare

Access to resources Recommend Favorite

Vaccine Adjuvants: Key Tools for Innovative Vaccine Design

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 20, 2013-10 ,pp. : 2562-2580

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases

By Gupta Kaveri  

Drugs in R&D, Vol. 9, Iss. 3, 2008-01 ,pp. : 137-145

Adis International

Access to resources Recommend Favorite